Abstract：Objective To explore the clinical effect of Qingjin Huatan Decoction in the treatment of stroke associated pneumonia. Methods A total of 80 patients with stroke associated pneumonia typed with syndrome of phlegm-heat obstructing lung treated in our hospital from February 2016 to July 2018 were selected as the research subjects, they were divided into control group and observation group according to the random number table method, with 40 cases in each group. The control group was treated with conventional antibiotics, the observation group was treated with Qingjin Huatan Decoction based on the control group. The traditional Chinese medicine symptom score and inflammatory indexes before and after treatment were compare between the two groups. The treatment effect were compared between the two groups. Results Before treatment, there was no significant difference in the score of traditional Chinese medicine symptoms between the two groups (P＞0.05). After treatment, the score of traditional Chinese medicine symptoms in the observation group was lower than that in the control group, the difference was statistically significant (P＜0.05). The total effective rate of treatment in the observation group was 95.00%, which was higher than 77.50% in the control group,the difference was statistically significant (P＜0.05). Before treatment, there were no significant differences in white blood cell count (WBC), neutrophil percentage, lymphocyte percentage, and C-reactive protein (CRP) levels between the two groups (P＞0.05). After treatment, the WBC, neutrophil percentage, and CRP levels in the observation group were lower than those in the control group, and the lymphocyte percentages was higher than that in the control group,the differences were statistically significant (P＜0.05). Conclusion Qingjin Huatan Decoction for the treatment of stroke associated pneumonia typed with syndrome of phlegm-heat obstructing lung can effectively improve patients′ traditional Chinese medicine symptom scores, alleviate inflammation, and is worthy of clinical promotion and application.
Heuschmann PU，Kolominsky-Rabas PL，Misselwitz B，et al.Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German stroke registers study group[J].ACC Cur J Rev，2004，13（12）：1761-1768.
[2]
Loewenstern J，Kessler RA，Caridi J，et al.Cost of oropharyngeal dysphagia after stroke：protocol for a systematic review[J].BMJ open，2018，8（12）：e022775.
京公网安备 11010502046607号